UGA Bulletin Logo

Bugs and Drugs: Biomedical Applications of Beneficial Microorganisms


Course Description

While microorganisms (bacteria, fungi, viruses) are often associated with disease, microbes can also promote good health in humans and animals. The purpose of this course is to develop an understanding as to how microorganisms, both naturally occurring and genetically modified, can be used to detect, treat, and prevent diseases.

Additional Requirements for Graduate Students:
Graduate students will be required to complete a written graded research proposal assignment along with their oral presentations. The exam questions will be different and appropriate to their grade level.


Athena Title

Bugs and Drugs


Prerequisite

MIBO 2500 or MIBO 2500E or MIBO 3500 or MIBO 3500E or MIBO 3500H


Undergraduate Pre or Corequisite

BIOL 1108 or BIOL 2108H


Semester Course Offered

Offered spring


Grading System

A - F (Traditional)


Student learning Outcomes

  • At the completion of this course, students should be able to describe specific genetic, physiological and structural features of microorganisms that make them advantageous for detecting and treating infectious and non-infectious diseases.
  • At the completion of this course, students should be able to evaluate the credibility of hypotheses, methods and interpretations from published studies and course assignments through reasoned analysis and consideration of alternative explanations to reach specific conclusions about the effectiveness of live biotherapeutic products in treating disease.
  • At the completion of this course, students should be able to identify and apply appropriate methods of data analysis (e.g., statistical tests) to interpret the results from published studies and publicly available datasets and to use effective verbal and graphical formats to communicate conclusions from live biotherapeutic research.
  • At the completion of this course, students should be able to design a live biotherapeutic system (bacteria, yeast or virus) using current experimental approaches and support the conclusions made about its ability to detect, diagnose or treat specific diseases, as well as consider ethical implications of its use as an alternative to more traditional disease treatments.

Topical Outline

  • Week 1 1. Introduction, course objectives 2. Fundamentals of microbiology, review 1 3. “Bugs as drugs”: history & general principles
  • Week 2 1. Probiotics, prebiotics, and postbiotics 2. Live biotherapeutic products (LBP) 3. Paper review 1
  • Week 3 1. Specific microbial systems: Lactic acid bacteria 2. E. coli Nissle 3. Bacillus & other Gram-positive species
  • Week 4 1. Yeast & fungi (e.g., Saccharomyces boulardii) 2. Viruses and bacteriophage 3. Paper review 2
  • Week 5 1. Targeting beneficial microorganisms to specific host systems 2. Humans (e.g., gut, lung, skin) 3. Humans, continued
  • Week 6 1. Animals (e.g., rumen) 2. Plants (rhizosphere and phyllosphere) 3. Paper review 3
  • Week 7 1. Insects & parasites 2. Midterm exam 3. Specific disease processes and their treatments
  • Week 8 1. Cancer 2. Metabolic diseases 3. Paper review 4
  • Week 9 1. Inflammatory diseases: IBD, Crohn’s diseases 2. Neurodegeneration 3. Infection
  • Week 10 1. Synthetic biology & genetic engineering 2. Methods of characterization 3. Paper review 5
  • Week 11 1. Engineering probiotics 2. Engineering LBPs 3. Antibiotic resistance and bacteriophage therapy
  • Week 12 1. Microbial canaries: microorganisms as biosensors 2. Engineering biosensors 3. Paper review 6
  • Week 13 1. Better together: Targeting the microbiome 2. Stay in your lane: Biocontainment systems 3. Regulatory & ethical considerations
  • Week 14 1. LBP Design presentations 1 2. LBP Design presentations 2 3. LBP Design presentations 3
  • Week 15 1. LBP Design presentations 4 2. LBP Design presentations 5 3. LBP Design presentations 6

Syllabus


Public CV